DETROIT, Feb. 1, 2011 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center has named David Gorski, M.D., Ph.D., leader of the Breast Multidisciplinary Team (MDT), effective Tuesday, Feb. 1. The announcement was made by Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos Cancer Institute.
As Breast MDT leader, Dr. Gorski is responsible for coordinating interdisciplinary collaboration among Karmanos' cancer experts to enhance the quality of patient care delivered by the medical team. He also is charged with promoting excellence in clinical cancer research and education, along with developing and implementing measures to improve the overall quality of patient care services provided by team members.
"I'm humbled and honored to have been chosen to be the leader of a team composed of such amazingly talented individuals," Dr. Gorski said. "It is my goal to continue the tradition of offering world-class care to every patient who comes to Karmanos."
In addition to Breast MDT leader, Dr. Gorski also serves as the co-director of the Comprehensive Breast Center and is co-leader of the Breast Cancer Biology Program at Karmanos and Wayne State University School of Medicine. Additionally, he is the site project director of the Michigan Breast Oncology Quality Initiative, a partnership between Karmanos and the University of Michigan, and serves as a professor of surgery at Wayne State University School of Medicine.
Dr. Gorski received his medical degree from the University of Michigan Medical School in Ann Arbor and received his Ph.D. in cellular physiology at Case Western Reserve University in Cleveland. Prior to joining Karmanos and Wayne State University School of Medicine, Dr. Gorski was an associate professor of Surgery at The Cancer Institute of New Jersey and the UMDNJ-Robert Wood Johnson Medical School in New Brunswick, NJ, as well as a member of the Joint Graduate Program in Cell & Developmental Biology at Rutgers University in Piscataway, N.J.
"Dr. Gorski has the breadth and depth of knowledge to effectively lead our very strong Breast Multidisciplinary Team," said Dr. Bepler. "At Karmanos, we pride ourselves on being the best when it comes to treating those with breast cancer. I have every confidence that Dr. Gorski will continue this very high standard of care."
Dr. Gorski came to Karmanos in 2008 and most recently served as co-leader of Karmanos' Breast MDT.
Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for nearly 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, Karmanos is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 physicians and researchers on faculty at the Wayne State University School of Medicine, and supported by thousands of volunteer and financial donors, Karmanos strives to prevent, detect and eradicate all forms of cancer. Its long-term partnership with the WSU School of Medicine enhances the collaboration of critical research and academics related to cancer care. Karmanos is southeastern Michigan's most preferred hospital for cancer care according to annual surveys conducted by the National Research Corporation. Gerold Bepler, M.D., Ph.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to www.karmanos.org.
SOURCE Karmanos Cancer Institute